news

Calixar to attend the Discovery on Target Summit in Boston

Anass JAWHARI, CSO of CALIXAR will be attending and presenting 2 posters on new exciting results at the DOT Summit in Boston in September 2017.

 

    • Poster 1 will describe the molecular architecture of human potassium chloride co-transporter KCC2.
    • Poster 2 will highlight the expression, solubilization, purification and characterization of native human CD20.

 

We will be happy to welcome you and discuss at the exhibition space during the poster sessions.

 

About Discovery on Target Summit 2017

 

Cambridge Healthtech Institute’s 15th Annual Discovery on Target, “The Industry’s Preeminent Event on Novel Drug Targets”, will once again gather over 1,200 drug discovery professionals in Boston, MA, this September 25-29, 2017. The event brings forth current and emerging “hot” targets, technologies and validation strategies for the development of novel small molecules and biologics.

 

Schedule a meeting: ajawhari@calixar.com

 ————————————————

DATES : September 25-29, 2017

MORE INFO : Discovery on Target